Assessing the Use of BotulinumtoxinA for Hyperactive Urinary Tract Dysfunction a Decade After Approval: General Versus Local Anesthesia for BotulinumtoxinA Detrusor Injection

Assessing the Use of BotulinumtoxinA for Hyperactive Urinary Tract Dysfunction a Decade After Approval: General Versus Local Anesthesia for BotulinumtoxinA Detrusor Injection

<b>Background</b>: The onabotulinumtoxinA detrusor injection (OnabotA DI) was approved a decade ago for the treatment of patients with idiopathic overactive bladder (iOAB) or neurogenic detrusor overactivity (nDO) dysfunction who had not been treated successfully otherwise. The procedure...

Full description

Saved in:
Bibliographic Details
Main Authors: Heinrich Schulte-Baukloh, Apostolos Apostolidis, Catarina Weiss, Thorsten Schlomm, Sarah Weinberger, Dirk Höppner, Kathrin Haberecht, Carsten Waskow, Hendrik Borgmann, Jörg Neymeyer, Bernhard Ralla
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Toxins
Subjects:
overactive bladder
neurogenic bladder
botulinumtoxinA detrusor injection
pain
anxiety
local anesthesia
Online Access:https://www.mdpi.com/2072-6651/16/11/462
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items